Let’s find out what your breast cancer is really made of. So we can treat it differently If you have advanced breast cancer that has progressed through multiple treatments, you may be eligible to participate in a new research study. This study begins with a molecular profile of your tumor which is now available …
Fairfax, VA — March 29, 2011 — The Side-Out Foundation is funding a study looking at a novel approach in treating patients living with advanced breast cancer. This clinical trial (SO-BCA-001) is laying the groundwork for biologically based treatments for breast cancer, utilizing molecular profiling of the patient’s tumor tissue to find potential targets and …
On July 22-25, 2009 the Eighth International Congress on the Future of Breast Cancer will be held in Maui, Hawaii. Dr. Lance Liotta who is a lead researcher in the Side-Out Clinical Trial, will be a featured speaker in the segment “Toward Personalized Breast Cancer Therapies”. His presentation is titled Deciphering the Dominant Signaling Pathways: …
Wow, I just got schooled. I just came from the President’s Series Program on Breast Cancer that INOVA put on featuring 2 folks from our advisory team, Dr. Edmiston and Dr. Robert. Ductal carcinoma in situ, estrogen receptors, aromatase inhibitors, yikes! How can I be invested in this cause when I have hardly a clue …
What in the world does “Crossing the Chasm”, a phrase coined by Geoffrey Moore, a business consultant, have to do with Breast Cancer. Quite frankly nothing. It just came to my mind of the metaphorical likenesses of the therapeutic stages of treating Breast Cancer. For a business in its early stage you are hoping to …
GMU, With Ties to Italy, Aims to Be a Biotech Force By Michael Laris Wednesday, February 27, 2008; B01 The tiny pieces of tumor, cut from 51 Italian cancer patients, arrived at a suburban Washington laboratory in boxes packed with dry ice. Doctors at the University of Padua had frozen 51 nubs of tissue taken …
In a Va. Lab, Forging Links to Speed Cancer Advances Read More »
The the emotional ups and downs of living with Metastatic Breast Cancer and probably all other Cancer diseases present a panoply of complexities that we try to navigate on a day to day basis. Both for the caregiver and the patient the challenges, risks and rewards are overwhelming. Fortunately for Gloria and I we have …
Daniel Von Hoff, MD is the Chief Scientific Officer for US Oncology Research. A truly inspiring leader, he is a graduate of Columbia College of Physicians and Surgeons. He has served as a Professor in multiple departments at the University of Texas Health Science Center in San Antonio, the University of Texas at Austin, and …
An Interview With Daniel Von Hof, M.D. “Context of Vulnerabilty” Read More »
As with so many, across the nation, being affected by this dreaded disease brings about the spirit of doing whatever you can to join the fight. For me I am focused on two priorities. First and foremost is being there for Glo, my loving wife of 46 years, who is the real fighter, and next …
Side-Out is a proud member of the
© The Side-Out Foundation is a 501(c)(3) non-profit organization. EIN 20-2510044
Dig Pink® is a registered trademark of the Side-Out Foundation
